Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Tue, 26.03.2024
Golding Capital Partners GmbH
After a successful year 2023 with €1.7 billion in new capital raised, Golding promotes Richard Wilmes, Head of Secondaries, to new partner
Munich, 26 March, 2024 – Golding Capital Partners, one of Europe's leading independent alternative investment asset managers, looks back on a positive 2023 and sets its course for the future. The promotion of [ … ]
Tue, 26.03.2024
SURTECO GROUP SE
SURTECO GROUP SE: Preliminary result for the business year 2023
Consolidated net sales achieves € 835.1 million
EBITDA at € 66.6 million, adjusted EBITDA at € 86.4 million
Buttenwiesen, 25 March 2024 – SURTECO GROUP SE has generated Group sales amounting to € 835.1 million according to unaudited preliminary figures presented. On the back of the [ … ]
Tue, 26.03.2024
MBB SE
MBB SE expects one billion euros in revenue with an EBITDA margin of 10% in 2024
Berlin, 26 March 2024 - MBB SE (ISIN DE000A0ETBQ4), a medium-sized family business, grew its revenues by 6.5% to €954.6 million in the 2023 financial year. The Group's adjusted EBITDA reached €80.2 million, compared to €93.2 million in the previous year. While the Ser [ … ]
Tue, 26.03.2024
JOST Werke SE
JOST closes fiscal year 2023 successfully and proposes a dividend of EUR 1.50 per share
JOST confirms preliminary results: Financial targets achieved in fiscal year 2023
Stable sales in 2023: Sales at EUR 1,250 million (2022: EUR 1,265 million)
Profitability significantly improved: Adjusted EBIT increases by 14% to EUR 141 million (2022: EUR 12 [ … ]
Tue, 26.03.2024
Defence Therapeutics Inc.
_________________________________________________________________
CSE: DTC FSE: DTC OTCQB: DTCFF PRESS RELEASE
DEFENCE’S SUCCESSFUL RESULTS ON ITS ACCUTOX® ANTI-CANCER ARMTM VACCINE CREATES A POTENT SECOND-GENERATION ANTI-CANCER ARM-002TM VACCINE
Vancouver, BC, Canada, March 26th, 2024 - Defence Therapeutics Inc. (“Defence” or [ … ]
Tue, 26.03.2024
CHAPTERS Group AG
In May 2023, the company placed the bearer bonds held by the company itself from the 2020 bond (ISIN: DE000A254TL0) and committed to an anchor investor to conduct one or more public buyback offers if certain conditions are met. In the meantime, the company has received funds from the repayment of shareholder loans issued in previous years. The Mana [ … ]
Tue, 26.03.2024
Viscom AG
Viscom AG closes 2023 financial year in line with forecast; very subdued start to 2024 financial year
Incoming orders: € 113,248 thousand (previous year: € 111,065 thousand, +2.0 %)
Revenue: € 118,780 thousand (previous year: € 105,518 thousand, +12.6 %)
EBIT: € 6,611 thousand (previous year: € 8,186 thousand, -19.2 %)
EBIT-Margin: 5.6 % (previ [ … ]
Tue, 26.03.2024
Marinomed Biotech AG
Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
Gulf-region specialist GAIA Healthcare FZ LLC obtains license for the marketing of Carragelose nasal sprays
Expansion of Carragelose partner network in Eastern Europe with VitaPlus Kft.
Korneuburg, Austria, 26 March 2024 – Marinomed Biotech AG [ … ]
Tue, 26.03.2024
Marinomed Biotech AG
Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
Gulf-region specialist GAIA Healthcare FZ LLC obtains license for the marketing of Carragelose nasal sprays
Expansion of Carragelose partner network in Eastern Europe with VitaPlus Kft.
Korneuburg, Austria, 26 March 2024 – Marinomed Biotech AG [ … ]
Tue, 26.03.2024
Friedrich Vorwerk Group SE
FRIEDRICH VORWERK generates revenues of €373 million in 2023 with an EBITDA margin of 8.6% and expects further sales and earnings growth in 2024 with an order backlog of €1 billion
Tostedt, March 26, 2024 - FRIEDRICH VORWERK Group SE (ISIN DE000A255F11), a leading provider of energy infrastructure solutions for gas, electricity and hydrogen applic [ … ]